Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	MHC class Ib protein binding	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	8.15e-07	16	233	5	GO:0023029
GeneOntologyMolecularFunction	MHC class Ib receptor activity	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.11e-06	19	233	5	GO:0032394
GeneOntologyMolecularFunction	ATP-dependent activity	ATP6V1B1 ATP6V1B2 MYH9 ERCC6 MYO7B SMARCAD1 ACSS2 MDN1 DNAH8 RAD51B ATP13A4 DNAH3 RHOBTB3 ABCC9 ATP13A5 FANCM KIF7 MACF1 KIF18B	1.14e-04	614	233	19	GO:0140657
GeneOntologyMolecularFunction	histone H3 demethylase activity	KDM3A KDM3B KDM2A KDM4A	2.97e-04	28	233	4	GO:0141052
GeneOntologyMolecularFunction	GTPase binding	KNTC1 GAS8 RABGAP1 RRAGB GOLGA4 RIC1 DOCK1 DOCK2 RHOBTB3 XPO4 EXOC5 SYTL4 GCC2	3.32e-04	360	233	13	GO:0051020
GeneOntologyMolecularFunction	small GTPase binding	KNTC1 GAS8 RABGAP1 GOLGA4 RIC1 DOCK1 DOCK2 RHOBTB3 XPO4 EXOC5 SYTL4 GCC2	4.12e-04	321	233	12	GO:0031267
GeneOntologyMolecularFunction	histone demethylase activity	KDM3A KDM3B KDM2A KDM4A	4.44e-04	31	233	4	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	KDM3A KDM3B KDM2A KDM4A	5.03e-04	32	233	4	GO:0140457
GeneOntologyMolecularFunction	histone H3K9 demethylase activity	KDM3A KDM3B KDM4A	5.19e-04	14	233	3	GO:0032454
GeneOntologyMolecularFunction	MHC protein binding	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	5.74e-04	58	233	5	GO:0042287
GeneOntologyMolecularFunction	ATP hydrolysis activity	ERCC6 SMARCAD1 MDN1 DNAH8 RAD51B ATP13A4 DNAH3 RHOBTB3 ABCC9 ATP13A5 FANCM KIF7 MACF1 KIF18B	7.13e-04	441	233	14	GO:0016887
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP6V1B1 ATP6V1B2 ATP13A4 ABCC9 ATP13A5	7.81e-04	62	233	5	GO:0019829
GeneOntologyMolecularFunction	tRNA (cytidine-3-)-methyltransferase activity	METTL2A METTL2B	8.01e-04	4	233	2	GO:0052735
GeneOntologyCellularComponent	endosome membrane	SLC29A3 HLA-DQB2 NEU3 VPS16 AP2S1 SNX27 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 ITM2B AP3D1 MRC1 ATP13A4 GRB14 ATP13A5 LAMP1 RUFY1 TMEM106B KIR3DL3 RAB21	3.46e-06	602	230	21	GO:0010008
GeneOntologyCellularComponent	endosome	MYH9 SLC29A3 HLA-DQB2 NEU3 VPS16 JAK2 EHBP1L1 SAMD9L AP2S1 OSBPL1A SNX27 AP1M1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 ITM2B AP3D1 MRC1 ATP13A4 GRB14 PTPN23 ATP13A5 LAMP1 RUFY1 TMEM106B SYTL4 KIR3DL3 PRKAR1A RAB21	1.35e-05	1167	230	30	GO:0005768
GeneOntologyCellularComponent	early endosome membrane	NEU3 VPS16 SNX27 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 ATP13A4 RUFY1 KIR3DL3 RAB21	2.43e-05	212	230	11	GO:0031901
GeneOntologyCellularComponent	vacuolar membrane	ATP6V1B1 ATP6V1B2 SLC29A3 HLA-DQB2 NEU3 RRAGB VPS16 PGAP6 AP2S1 AP1M1 PRMT1 AP3D1 SZT2 LAMP1 TMEM106B RRAGA ENPEP	4.98e-05	507	230	17	GO:0005774
GeneOntologyCellularComponent	lysosomal membrane	ATP6V1B2 SLC29A3 HLA-DQB2 NEU3 RRAGB VPS16 PGAP6 AP2S1 AP1M1 PRMT1 AP3D1 SZT2 LAMP1 TMEM106B RRAGA ENPEP	5.69e-05	462	230	16	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	ATP6V1B2 SLC29A3 HLA-DQB2 NEU3 RRAGB VPS16 PGAP6 AP2S1 AP1M1 PRMT1 AP3D1 SZT2 LAMP1 TMEM106B RRAGA ENPEP	5.69e-05	462	230	16	GO:0098852
GeneOntologyCellularComponent	early endosome	HLA-DQB2 NEU3 VPS16 SAMD9L SNX27 AP1M1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 AP3D1 ATP13A4 PTPN23 RUFY1 KIR3DL3 RAB21	9.12e-05	481	230	16	GO:0005769
GeneOntologyCellularComponent	vesicle membrane	ATP6V1B1 ATP6V1B2 SLC29A3 HLA-DQB2 GPR84 NEU3 VPS16 CACNG2 AP2S1 SNX27 AP1M1 KIR2DL1 KIR2DL3 ANXA9 KIR3DL1 KIR3DL2 ITM2B AP3D1 MRC1 ATP13A4 GRB14 ATP13A5 LAMP1 RUFY1 TMEM106B SYTL4 KIR3DL3 RAB21	7.00e-04	1325	230	28	GO:0012506
GeneOntologyCellularComponent	Gtr1-Gtr2 GTPase complex	RRAGB RRAGA	7.13e-04	4	230	2	GO:1990131
Domain	KRAB	ZNF157 ZNF549 ZNF214 ZNF626 ZNF441 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 ZNF33A ZNF431 ZNF528	2.46e-06	358	231	17	PS50805
Domain	KRAB	ZNF157 ZNF549 ZNF214 ZNF626 ZNF441 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 ZNF33A ZNF431 ZNF528	2.46e-06	358	231	17	PF01352
Domain	KRAB	ZNF157 ZNF549 ZNF214 ZNF626 ZNF441 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 ZNF33A ZNF431 ZNF528	3.70e-06	369	231	17	SM00349
Domain	KRAB	ZNF157 ZNF549 ZNF214 ZNF626 ZNF441 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 ZNF33A ZNF431 ZNF528	3.83e-06	370	231	17	IPR001909
Domain	ARM-type_fold	IFT172 UNC45A CLHC1 UTP20 AP3D1 DOCK1 DOCK2 XPO4 RALGAPA2 VIRMA PPP4R4 PPP2R5B PPP2R5E ARVCF EFR3B CFAP69	5.30e-06	339	231	16	IPR016024
Domain	zf-C2H2	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF ZNF106 ZNF33A ZNF335 ZNF431 ZNF528	1.76e-05	693	231	23	PF00096
Domain	-	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF ZNF33A ZNF335 ZNF431 ZNF528	3.88e-05	679	231	22	3.30.160.60
Domain	Znf_C2H2-like	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF KAT7 ZNF106 ZNF33A ZNF335 ZNF431 ZNF528	5.36e-05	796	231	24	IPR015880
Domain	Znf_C2H2/integrase_DNA-bd	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF ZNF33A ZNF335 ZNF431 ZNF528	5.36e-05	694	231	22	IPR013087
Domain	Znf_C2H2	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF KAT7 ZNF106 ZNF33A ZNF335 ZNF431 ZNF528	6.39e-05	805	231	24	IPR007087
Domain	ZnF_C2H2	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF KAT7 ZNF106 ZNF33A ZNF335 ZNF431 ZNF528	6.77e-05	808	231	24	SM00355
Domain	ZINC_FINGER_C2H2_2	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF ZNF106 ZNF33A ZNF335 ZNF431 ZNF528	9.78e-05	775	231	23	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF ZNF106 ZNF33A ZNF335 ZNF431 ZNF528	1.02e-04	777	231	23	PS00028
Domain	P-loop_NTPase	ATP6V1B1 ATP6V1B2 MYH9 SAMD9 ERCC6 MYO7B SMARCAD1 RRAGB NDUFA10 SAMD9L MDN1 DNAH8 NLRP8 RAD51B DNAH3 RHOBTB3 APAF1 ABCC9 RHOT2 FANCM KIF7 RRAGA KIF18B RAB21	1.42e-04	848	231	24	IPR027417
Domain	TFIIA_asu_N	GTF2A1L GTF2A1	1.52e-04	2	231	2	IPR013028
Domain	TFIIA_asu/bsu	GTF2A1L GTF2A1	1.52e-04	2	231	2	IPR004855
Domain	V-ATPase_su_B/beta	ATP6V1B1 ATP6V1B2	1.52e-04	2	231	2	IPR022879
Domain	TFIIA	GTF2A1L GTF2A1	1.52e-04	2	231	2	SM01371
Domain	TFIIA	GTF2A1L GTF2A1	1.52e-04	2	231	2	PF03153
Domain	-	GTF2A1L GTF2A1	1.52e-04	2	231	2	1.10.287.100
Domain	ATPase_V1-cplx_bsu	ATP6V1B1 ATP6V1B2	1.52e-04	2	231	2	IPR005723
Domain	JmjC	KDM3A KDM3B KDM2A KDM4A	1.99e-04	24	231	4	PF02373
Domain	-	ATP6V1B1 ATP6V1B2 SAMD9 ERCC6 MYO7B SMARCAD1 RRAGB NDUFA10 SAMD9L MDN1 DNAH8 NLRP8 RAD51B DNAH3 RHOBTB3 APAF1 ABCC9 RHOT2 FANCM RRAGA RAB21	4.01e-04	746	231	21	3.40.50.300
Domain	-	GTF2A1L GTF2A1	4.53e-04	3	231	2	2.30.18.10
Domain	TFIIA_b-brl	GTF2A1L GTF2A1	4.53e-04	3	231	2	IPR009088
Domain	-	RIPOR3 UNC45A UTP20 AP3D1 XPO4 PPP4R4 PPP2R5E ARVCF EFR3B CFAP69	4.59e-04	222	231	10	1.25.10.10
Domain	ARM-like	RIPOR3 UNC45A UTP20 AP3D1 DOCK2 XPO4 PPP4R4 PPP2R5E ARVCF EFR3B CFAP69	5.63e-04	270	231	11	IPR011989
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH8 DNAH3	6.15e-04	14	231	3	IPR011704
Domain	AAA_5	MDN1 DNAH8 DNAH3	6.15e-04	14	231	3	PF07728
Domain	JMJC	KDM3A KDM3B KDM2A KDM4A	6.25e-04	32	231	4	PS51184
Domain	JmjC_dom	KDM3A KDM3B KDM2A KDM4A	6.25e-04	32	231	4	IPR003347
Domain	JmjC	KDM3A KDM3B KDM2A KDM4A	7.04e-04	33	231	4	SM00558
Domain	P5-ATPase	ATP13A4 ATP13A5	8.99e-04	4	231	2	PF12409
Domain	MARK/par1	MARK3 MARK2	8.99e-04	4	231	2	IPR033624
Domain	Gtr1_RagA	RRAGB RRAGA	8.99e-04	4	231	2	IPR006762
Domain	MeTrfase	METTL2A METTL2B	8.99e-04	4	231	2	IPR026113
Domain	Gtr1_RagA	RRAGB RRAGA	8.99e-04	4	231	2	PF04670
Domain	TFIIA_a-hlx	GTF2A1L GTF2A1	8.99e-04	4	231	2	IPR009083
Domain	PP2A_B56	PPP2R5B PPP2R5E	1.49e-03	5	231	2	IPR002554
Domain	DOCK_N	DOCK1 DOCK2	1.49e-03	5	231	2	PF16172
Domain	DOCK_N	DOCK1 DOCK2	1.49e-03	5	231	2	IPR032376
Domain	ATP_synth_asu_C	ATP6V1B1 ATP6V1B2	1.49e-03	5	231	2	IPR000793
Domain	ATP-synt_ab_N	ATP6V1B1 ATP6V1B2	1.49e-03	5	231	2	PF02874
Domain	KA1	MARK3 MARK2	1.49e-03	5	231	2	PF02149
Domain	P-type_TPase_V	ATP13A4 ATP13A5	1.49e-03	5	231	2	IPR006544
Domain	ATPase_F1/V1/A1_a/bsu_N	ATP6V1B1 ATP6V1B2	1.49e-03	5	231	2	IPR004100
Domain	B56	PPP2R5B PPP2R5E	1.49e-03	5	231	2	PF01603
Domain	KA1_dom	MARK3 MARK2	1.49e-03	5	231	2	IPR001772
Domain	ATPase_a/bsu_AS	ATP6V1B1 ATP6V1B2	1.49e-03	5	231	2	IPR020003
Domain	ATP-synt_ab_C	ATP6V1B1 ATP6V1B2	1.49e-03	5	231	2	PF00306
Domain	KA1	MARK3 MARK2	1.49e-03	5	231	2	PS50032
Domain	ATP-synt_ab	ATP6V1B1 ATP6V1B2	1.49e-03	5	231	2	PF00006
Domain	-	MARK3 MARK2	1.49e-03	5	231	2	3.30.310.80
Domain	ATPASE_ALPHA_BETA	ATP6V1B1 ATP6V1B2	1.49e-03	5	231	2	PS00152
Pubmed	A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.54e-12	8	236	6	15730517
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.63e-10	14	236	6	19875891
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.63e-10	14	236	6	19489269
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.63e-10	14	236	6	15896204
Pubmed	Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.86e-10	7	236	5	12618911
Pubmed	Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.86e-10	7	236	5	15748957
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	4.36e-10	15	236	6	20082646
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	4.36e-10	15	236	6	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	4.36e-10	15	236	6	19926642
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	4.36e-10	15	236	6	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	4.36e-10	15	236	6	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	4.36e-10	15	236	6	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	18668235
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	16403292
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	20652381
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	18643961
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	20331834
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.93e-10	16	236	6	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	20650299
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	19032228
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	20483367
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	19218127
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.07e-09	17	236	6	19761533
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3A ERCC6 BCORL1 ZSCAN26 KDM3B SMARCAD1 TRIM24 FSIP2 USP7 MLLT6 TAF1 HERC2 AHCTF1 RFX1 RLF KAT7 SENP6 KDM2A KDM4A KIF18B ZMYM4	1.43e-09	608	236	21	36089195
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.59e-09	18	236	6	19630074
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.59e-09	18	236	6	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.59e-09	18	236	6	19046302
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.59e-09	18	236	6	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.59e-09	18	236	6	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.59e-09	18	236	6	19846535
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.59e-09	18	236	6	20210918
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2	1.70e-09	9	236	5	7749980
Pubmed	[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.07e-09	4	236	4	18269867
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.31e-09	19	236	6	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.31e-09	19	236	6	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.31e-09	19	236	6	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	2.31e-09	19	236	6	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	3.28e-09	20	236	6	20193031
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2	3.38e-09	10	236	5	12559621
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	4.56e-09	21	236	6	19861144
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	6.24e-09	22	236	6	20492596
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MYH9 MARK3 VPS16 SAP30 PTCHD1 AP2S1 DIMT1 DBF4 USP7 NHS PRMT1 SZT2 YBEY ACAD9 PROCR XPO4 RUFY1 VIRMA PPP4R4 KCTD17 RLF KAT7 ZNF106 PPP2R5E CTR9 RRAGA PRKAR1A KDM2A KDM4A ZMYM4	8.94e-09	1327	236	30	32694731
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L KNTC1 FARP2 SMYD4 SAMD9L ZNF347 RIC1 DOCK2 PTPN23 GPAM FANCM RALGAPA2 PPP4R4 ATRNL1 TTC21B MACF1 KDM2A RAB21	9.52e-09	493	236	18	15368895
Pubmed	Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2	1.03e-08	5	236	4	7716543
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.05e-08	12	236	5	17490516
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DL1 KIR2DL2 KIR3DL1 KIR3DL2 KIR3DL3	2.63e-08	14	236	5	18945962
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SECISBP2L PALD1 IFT172 NDUFA10 AP2S1 HOOK1 SCML1 OSBPL1A SNX27 PRMT1 TCTN1 EXOC6 ACAD9 XPO4 RFX1 KIF7 MAPRE3 EXOC5 PPP2R5E CTR9 GCC2 TTC21B DZIP3 COPS4 PRKAR1A MARK2 KIF18B RAB21 LARGE1	3.05e-08	1321	236	29	27173435
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	3.82e-08	29	236	6	20082482
Pubmed	Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2	7.12e-08	7	236	4	26928464
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DL1 KIR2DL2 KIR3DL1 KIR3DL2	7.12e-08	7	236	4	14607943
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2 KIR3DL3	7.98e-08	17	236	5	20173784
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL3	7.98e-08	17	236	5	19169284
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP6V1B2 MARK3 BCKDK SMARCAD1 UNC45A TRIM24 MDN1 SUPT6H CCDC138 HERC2 ITM2B AP3D1 GOLGA4 ACAD9 AHCTF1 APAF1 SHMT1 KIF7 CDC37 GTF2A1 EXOC5 AKAP9 ARHGEF10 EIF2S1 CTR9 COPS4 EFR3B PRKAR1A MACF1 MARK2	1.09e-07	1487	236	30	33957083
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.26e-07	35	236	6	19683555
Pubmed	Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.42e-07	8	236	4	20935224
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2	1.42e-07	8	236	4	9430221
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYH9 ERCC6 SMARCAD1 VPS16 UNC45A AP2S1 MDN1 DIMT1 USP7 SNX27 AP1M1 UTP20 PRMT1 HERC2 AP3D1 GOLGA4 AHCTF1 PTPN23 RHOT2 RLF CDC37 KAT7 ARVCF EIF2S1 CTR9 MACF1 KDM2A KIF18B	1.81e-07	1353	236	28	29467282
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DL1 KIR2DL2 KIR3DL1 KIR3DL2 KIR3DL3	1.97e-07	20	236	5	20426625
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYH9 ACACB BCORL1 RABGAP1 UNC45A NDUFA10 TRIM24 TAF1 KNL1 BRMS1L RFX1 RUFY1 RLF GCC2 ZMYM4	2.10e-07	418	236	15	34709266
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2	2.54e-07	9	236	4	8662091
Pubmed	Distribution of KIR genes in the Czech population.	KIR2DL1 KIR3DL1 KIR3DL2 KIR3DL3	2.54e-07	9	236	4	18186800
Pubmed	Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.	KIR2DL1 KIR2DL3 KIR3DL1	3.09e-07	3	236	3	30698860
Pubmed	PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L.	SAMD9 SAMD9L PARP14	3.09e-07	3	236	3	37612499
Pubmed	[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].	KIR2DL1 KIR2DL2 KIR2DL3	3.09e-07	3	236	3	19549382
Pubmed	Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.	KIR2DL1 KIR2DL2 KIR2DL3	3.09e-07	3	236	3	15879158
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KDM3A CYP2C18 KDM3B SMARCAD1 SAP30 MDN1 DBF4 USP7 UTP20 ANXA9 GOLGA4 RFX1 VIRMA ZNF106 CTR9 ZNF335 FTH1 SENP6 MARK2 ZMYM4	4.01e-07	774	236	20	15302935
Pubmed	Distinctive KIR and HLA diversity in a panel of north Indian Hindus.	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2	4.20e-07	10	236	4	11904677
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ACACB BCORL1 KDM3B TRIM24 EHBP1L1 MDN1 KNL1 EXOC6 ATP13A4 RHOT2 RFX1 VIRMA PPP4R4 KIF7 ARVCF GCC2 RAB21 IL17RD	4.45e-07	638	236	18	31182584
Pubmed	Natural killer cells and immune surveillance.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.57e-07	11	236	4	18830515
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	6.57e-07	11	236	4	19664392
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ERCC6 SMARCAD1 TRIM24 SAP30 DIMT1 SCML1 USP7 TAF1 ARAP2 KNL1 BAHCC1 INO80E YBEY RHOBTB3 ZNF212 AHCTF1 RHOT2 BRMS1L RALGAPA2 KIF7 KAT7 PPP2R5E MACF1 KIF18B	7.39e-07	1116	236	24	31753913
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	KNTC1 ATP6V1B2 MYH9 KDM3B SMARCAD1 RABGAP1 RRAGB UNC45A EHBP1L1 DIMT1 USP7 AP1M1 PRMT1 AP3D1 SHMT1 PTPN23 LAMP1 RUFY1 CDC37 GTF2A1 PPP2R5E ARHGEF10 EIF2S1 CTR9 FTH1 COPS4 PRKAR1A MACF1	7.69e-07	1455	236	28	22863883
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PALD1 MARK3 IFT172 SMARCAD1 SNX27 ARAP2 VIRMA EPG5 PPP2R5E AKAP9 GCC2 DZIP3 MACF1 LARGE1	8.89e-07	407	236	14	12693553
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	9.80e-07	12	236	4	20371502
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	9.80e-07	12	236	4	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	9.80e-07	12	236	4	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2	9.80e-07	12	236	4	20137308
Pubmed	B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.	KIR2DL1 KIR2DL2 KIR2DL3	1.23e-06	4	236	3	20056126
Pubmed	Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.	KIR2DL1 KIR2DL3 KIR3DL1	1.23e-06	4	236	3	18632158
Pubmed	Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.	KIR2DL1 KIR2DL2 KIR2DL3	1.23e-06	4	236	3	25037176
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2 KIR2DL3	1.23e-06	4	236	3	26542066
Pubmed	[Differential expression levels of killer immunoglobin-like receptor genotype in patients with hematological malignancies between high-risk and standard-risk groups].	KIR2DL1 KIR3DL1 KIR3DL2	1.23e-06	4	236	3	18718052
Pubmed	HLA-C and KIR genes in hepatitis C virus infection.	KIR2DL1 KIR2DL2 KIR2DL3	1.23e-06	4	236	3	16571411
Pubmed	High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.	KIR2DL2 KIR2DL3 KIR3DL1	1.23e-06	4	236	3	19522772
Pubmed	[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].	KIR2DL1 KIR2DL2 KIR2DL3	1.23e-06	4	236	3	18543232
Pubmed	NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.	KIR2DL1 KIR2DL3 KIR3DL1	1.23e-06	4	236	3	27732638
Pubmed	Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.	KIR2DL1 KIR2DL3 KIR3DL1	1.23e-06	4	236	3	23354323
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	GAS8 ZNF214 PP2D1 JAK2 SAMD9L HOOK1 CEP126 GOLGA4 GTF2A1L XPO4 RALGAPA2 TMEM106B PPP2R5B GCC2 EFR3B RAB21 IL17RD ALPK2	1.25e-06	686	236	18	29987050
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	1.41e-06	13	236	4	19934297
Cytoband	19q13.4	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2	5.69e-05	79	236	5	19q13.4
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	NLRP11 LGALS16 ZNF549 AP2S1 ZNF347 ZNF534 PRMT1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 ZNF614 NLRP8 KLK11 ZNF546 KIR3DL3 ZNF528	1.65e-04	1192	236	17	chr19q13
Cytoband	12q23	UTP20 APAF1	3.89e-04	6	236	2	12q23
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	8.01e-09	18	162	6	620
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF157 ZNF549 ZSCAN26 ZNF214 ZNF626 ZNF441 ZNF117 ZNF276 ZNF394 ZNF257 ZNF347 ZNF534 ZNF614 ZNF730 ZNF212 ZNF57 ZNF546 RLF ZNF106 ZNF33A ZNF335 ZNF431 ZNF528	1.14e-07	718	162	23	28
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM3A KDM3B KDM2A KDM4A	5.74e-05	24	162	4	485
GeneFamily	LIM zinc finger domain containing\|LIM domain containing	LIMS4 LIMS3	4.73e-04	4	162	2	1163
GeneFamily	Parkinson disease associated genes\|ATPase orphan transporters	ATP13A4 ATP13A5	7.84e-04	5	162	2	1213
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CD300C KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 MRC1 PROCR LAMP1 KIR3DL3 ENPEP	8.67e-04	394	162	11	471
GeneFamily	Sterile alpha motif domain containing	SAMD9 SAMD9L SCML1 ARAP2 CNKSR3	1.17e-03	88	162	5	760
GeneFamily	Zinc fingers MYM-type	ZMYM1 ZMYM4	1.17e-03	6	162	2	86
GeneFamily	Exocyst complex	EXOC6 EXOC5	2.76e-03	9	162	2	1055
GeneFamily	Glycosyltransferase family 8	LARGE2 LARGE1	2.76e-03	9	162	2	436
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SECISBP2L KDM3A MARK3 KDM3B RABGAP1 TRIM24 ADORA2B MDN1 DBF4 USP7 UTP20 GOLGA4 ARAP2 DOCK1 RHOBTB3 AHCTF1 BHLHE40 RLF PPP2R5E AKAP9 ARHGEF10 GCC2 MACF1 RAB21 ZMYM4	2.46e-07	856	235	25	M4500
Coexpression	GSE4142_NAIVE_VS_GC_BCELL_UP	MYH9 LHX8 FARP2 OSBPL1A MLLT6 INO80E DOCK2 CCDC80 FTH1 TTC21B ALPK2	1.99e-06	199	235	11	M6375
Coexpression	GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	ATP6V1B2 SAMD9 ACACB JAK2 RHOBTB3 RLF ZNF106 PPP2R5B FTH1 EFR3B SENP6	2.09e-06	200	235	11	M5416
Coexpression	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	SECISBP2L ACACB BMP7 ZNF117 ZNF394 SUPT6H UTP20 ZNF614 DOCK1 RC3H2 GRK4 AHCTF1 ARHGEF10 ZMYM4 METTL2B	2.56e-05	471	235	15	M19016
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	IFT172 GAS8 CCDC191 IMPG2 SZT2 PTPN23 RFX1 ZNF33A KDM2A KDM4A CFAP69	1.51e-09	166	236	11	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SAMD9 CEP126 AP3D1 GOLGA4 ABCC9 TMEM106B PPP2R5E AKAP9 GCC2 DZIP3 SPAG17	1.01e-08	199	236	11	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GPC3 NHS SCARA3 COL16A1 ITGA8 CCDC80 SNED1 SYTL4 MACF1 CFAP69	1.06e-07	197	236	10	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	OSBPL1A AP3D1 GOLGA4 ABCC9 TMEM106B KLHL5 PPP2R5E AKAP9 GCC2 DZIP3	1.17e-07	199	236	10	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 JAK2 SAMD9L GOLGA4 ARAP2 PARP14 AKAP9 OASL MACF1 KDM2A	1.23e-07	200	236	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 TTC16 SAMD9L MLLT6 KIR3DL2 GOLGA4 ARAP2 BHLHE40 AKAP9 MACF1	1.23e-07	200	236	10	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	SAMD9 SAMD9L ZNF394 GOLGA4 PARP14 BHLHE40 GCC2 OASL FTH1	9.47e-07	193	236	9	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	ATP6V1B1 GOLGA4 ABCC9 TMEM106B ZNF106 KLHL5 PPP2R5E AKAP9 GCC2	1.22e-06	199	236	9	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SAMD9 ZNF257 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 RC3H2 KIR3DL3	4.09e-06	173	236	8	79d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 NEU3 RABGAP1 PHKB KNL1 MMS22L PPP4R4 KIF18B	5.26e-06	179	236	8	4166c4e1a8748a79ac6a11fd0b97c5344be2321b
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSCAN26 FARP2 TREML1 DNAH8 ITGA8 CCDC80 ARHGEF10 NIM1K	5.26e-06	179	236	8	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GPC3 INO80E ABCC9 ATP13A5 KIF7 SENP6 ENPEP	8.62e-06	137	236	7	9324b55eac55e0cc1e8e450a4b5374d12e9587a3
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GPC3 INO80E ABCC9 ATP13A5 KIF7 SENP6 ENPEP	8.62e-06	137	236	7	032f8409d0d179e254c8ff632afbda78852a9889
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GPC3 INO80E ABCC9 ATP13A5 KIF7 SENP6 ENPEP	8.62e-06	137	236	7	265a4a50e48b13c8b3b0730f818235f71fbd6baa
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 MAMDC2 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.78e-06	192	236	8	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 MAMDC2 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.78e-06	192	236	8	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 MAMDC2 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	9.83e-06	195	236	8	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 MAMDC2 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	9.83e-06	195	236	8	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CEP126 CCDC191 TCTN1 DNAH3 MAPRE3 DZIP3 SPAG17 CFAP69	1.06e-05	197	236	8	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CEP126 DNAH3 CCDC80 AKAP9 DZIP3 SPAG17 CFAP69	1.06e-05	197	236	8	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CEP126 DNAH3 CCDC80 AKAP9 DZIP3 SPAG17 CFAP69	1.06e-05	197	236	8	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CEP126 DNAH3 CCDC80 AKAP9 DZIP3 SPAG17 CFAP69	1.06e-05	197	236	8	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CEP126 DNAH3 CCDC80 AKAP9 DZIP3 SPAG17 CFAP69	1.06e-05	197	236	8	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	SAMD9 SAMD9L ZNF394 GOLGA4 PARP14 BHLHE40 OASL KDM2A	1.06e-05	197	236	8	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	severe_COVID-19-NK\|World / disease group, cell group and cell class (v2)	ZNF276 MLLT6 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 RHOBTB3 BHLHE40	1.10e-05	198	236	8	36b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCell	mild-Lymphocytic-NK_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MLLT6 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 RHOBTB3 BHLHE40 MACF1	1.10e-05	198	236	8	dce3c008757786aa6bd4a869456b76b4cbbb1d5b
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	SAMD9 SAMD9L ZNF394 GOLGA4 PARP14 BHLHE40 OASL KDM2A	1.10e-05	198	236	8	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 SAMD9L ZNF394 GOLGA4 PARP14 BHLHE40 OASL KDM2A	1.10e-05	198	236	8	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	ATP6V1B1 UNC45A AP3D1 GOLGA4 KLHL5 PPP2R5E AKAP9 GCC2	1.14e-05	199	236	8	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 TTC16 SAMD9L MLLT6 GOLGA4 ARAP2 OASL MACF1	1.18e-05	200	236	8	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	mild-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 SAMD9L MLLT6 KIR2DL3 KIR3DL1 ARAP2 RHOBTB3 MACF1	1.18e-05	200	236	8	a11fb1d7e124c352eb73fea0e0ec0fed577c97f7
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYH9 HLA-DQB2 CCDC191 LARGE2 VIRMA MACF1 LARGE1	1.92e-05	155	236	7	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_C\|367C / Donor, Lineage, Cell class and subclass (all cells)	TOPAZ1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3 KIF18B	2.01e-05	156	236	7	a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TOPAZ1 CYTL1 KIR2DL1 KIR2DL3 KIR3DL2 KIR3DL3 KIF18B	2.01e-05	156	236	7	e6798d2b9c2c1fc6525c24f596f25aa85a375651
ToppCell	COVID-CD8-exh_CD4\|COVID / Condition, Cell_class and T cell subcluster	CLHC1 NHS ZNF614 PTPN23 ZNF57 RFX1 RLF	2.99e-05	166	236	7	4ca8c91b03d08489f244898cf9423b9d10348bc8
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	BCORL1 SAMD9L OSBPL1A TCTN1 MRC1 COL16A1 ZNF57	3.35e-05	169	236	7	0589f39d8e9468e42d25d30ff70bb7cb8b921628
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GPC3 CEP126 CCDC191 DNAH3 SNED1 SPAG17 CFAP69	3.35e-05	169	236	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 ERCC6 SMYD4 DIMT1 HOOK1 BAHCC1 TTC21B	3.48e-05	170	236	7	d70aaa0f4e5034bb9f61b832b5f9123870936d3c
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	KNTC1 KIR2DL3 KIR3DL1 KIR3DL2 KNL1 KIR3DL3 KIF18B	3.61e-05	171	236	7	4ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	HOOK1 KIR3DL1 DNAH3 GPAM ARHGEF10 NIM1K LARGE1	4.03e-05	174	236	7	110369f6b78de34a6d934b5b47cecd023347bc80
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	ACACB ACSS2 ZNF117 OSBPL1A NHS RHOBTB3 GPAM	4.66e-05	178	236	7	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	367C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF441 CEP126 ARAP2 ITGA8 KCTD17 KDM4A ZMYM4	4.83e-05	179	236	7	5aa8465e943b6b666c7f8b1937fcc3764bfe91f6
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TTC16 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3 MACF1	5.00e-05	180	236	7	1c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TTC16 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3 MACF1	5.00e-05	180	236	7	ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KCNB2 HOXB3 MAMDC2 NHS SCARA3 ITGA8 ATRNL1	5.00e-05	180	236	7	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TTC16 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3 MACF1	5.00e-05	180	236	7	0a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EMILIN2 ADORA2B GPC3 ANXA9 SCARA3 MMS22L CCDC80	5.18e-05	181	236	7	c7f5aedcb74c21fb587a95a16d700e2a38a380ee
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EMILIN2 ADORA2B GPC3 ANXA9 SCARA3 MMS22L CCDC80	5.18e-05	181	236	7	0ec9621a078d004bbd25a587757d24b5cf162959
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PGAP6 JAK2 PTCHD1 MLLT6 BHLHE40 POLR3C RAB21	5.95e-05	185	236	7	19fa853f6f746ccf232a343b3c9c7a5e55800409
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	SAMD9 TTC16 SAMD9L KIR2DL1 KIR3DL1 KIR3DL2 OASL	6.36e-05	187	236	7	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	ACACB ACSS2 ZNF117 OSBPL1A NHS SHMT1 GPAM	6.58e-05	188	236	7	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TTC16 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 ARAP2 KIR3DL3	6.58e-05	188	236	7	0a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 TTC16 SAMD9L KIR2DL1 KIR3DL1 KIR3DL2 OASL	7.03e-05	190	236	7	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TTC16 SMYD4 HOOK1 SNX27 UTP20 RRAGA OASL	7.03e-05	190	236	7	2434b8ad2976eab7d9147012c28454ab29670709
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPC3 NHS SCARA3 COL16A1 ITGA8 CCDC80 CFAP69	7.03e-05	190	236	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 TTC16 SAMD9L KIR2DL1 KIR3DL1 KIR3DL2 OASL	7.03e-05	190	236	7	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SAMD9 TTC16 SAMD9L KIR2DL1 KIR3DL1 KIR3DL2 OASL	7.03e-05	190	236	7	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SAMD9 TTC16 SAMD9L KIR2DL1 KIR3DL1 KIR3DL2 OASL	7.03e-05	190	236	7	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	MS-CD8-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	SAMD9 TTC16 KLK11 AHCTF1 BHLHE40 GTF2A1 MARK2	7.03e-05	190	236	7	8c831c4560b8e70f92b4c15644fea39f7f7afcf2
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KNTC1 NHS ZNF730 KNL1 MMS22L SHMT1 KIF18B	7.03e-05	190	236	7	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B GPC3 MAMDC2 ITGA8 ABCC9 ARVCF ENPEP	7.27e-05	191	236	7	5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TTC16 SMYD4 HOOK1 SNX27 UTP20 RRAGA OASL	7.27e-05	191	236	7	39ef8e1d7cc3ebb11717e8a55501515e3b72b177
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB RIPOR3 HOXB3 ITM2B RAD51B RHOBTB3 ITGA8	7.51e-05	192	236	7	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPC3 NHS SCARA3 COL16A1 ITGA8 CCDC80 CFAP69	7.51e-05	192	236	7	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPC3 NHS SCARA3 COL16A1 ITGA8 CCDC80 CFAP69	7.51e-05	192	236	7	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	7.76e-05	193	236	7	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	ICU-SEP-Lymphocyte-T_NK-NK\|ICU-SEP / Disease, Lineage and Cell Type	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 RHOBTB3 ARHGEF10 KIR3DL3	7.76e-05	193	236	7	f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell	COVID-19_Severe-CD8+_T_activated\|World / disease group, cell group and cell class	SAMD9 TTC16 SAMD9L KIR2DL1 KIR3DL1 KIR3DL2 OASL	7.76e-05	193	236	7	ddc1db516568e03be8e82b2ca770c67756418185
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KNTC1 NHS ZNF730 KNL1 MMS22L ATRNL1 KIF18B	7.76e-05	193	236	7	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	7.76e-05	193	236	7	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPC3 MAMDC2 NHS COL16A1 ITGA8 CCDC80 SNED1	7.76e-05	193	236	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC16 SAP30 KIR2DL3 KIR3DL1 BHLHE40 OASL MACF1	8.01e-05	194	236	7	24837a27b0041fe8c348225fa8b09b127d743603
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPC3 NHS COL16A1 ITGA8 CCDC80 SNED1 CFAP69	8.01e-05	194	236	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	PBMC-Mild\|PBMC / Compartment, Disease Groups and Clusters	MYH9 SAMD9 SAMD9L ZNF276 PARP14 BHLHE40 OASL	8.01e-05	194	236	7	d1366b169d14011194e61d16b6b0953349febc78
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.27e-05	195	236	7	b616ee6f1d878935d293c8e0a8bbc5b4385301f0
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.27e-05	195	236	7	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CEP126 DNAH3 DUOX2 CCDC80 DZIP3 SPAG17 CFAP69	8.27e-05	195	236	7	d211a836cf711fdb91b10d512f09d462be937cc5
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.27e-05	195	236	7	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CEP126 TCTN1 DNAH3 MAPRE3 DZIP3 SPAG17 CFAP69	8.27e-05	195	236	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.27e-05	195	236	7	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND07-Mesenchymal-Mesenchymal_structural\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.27e-05	195	236	7	2f9a274b26fc528a85f50933ec2f4db1dc9da0ca
ToppCell	COVID-19-Lymphoid-CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	TTC16 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 ARAP2 OASL	8.27e-05	195	236	7	d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CEP126 DNAH3 DUOX2 CCDC80 DZIP3 SPAG17 CFAP69	8.27e-05	195	236	7	79dc031258579ea328181dda33710dd897f1064a
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPC3 ITGA8 CCDC80 PPP4R4 SNED1 MACF1 ENPEP	8.27e-05	195	236	7	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MLLT6 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 RHOBTB3 ARVCF	8.54e-05	196	236	7	9b3848dd4256cd6d9a21ef6bfdbd0cb7c0030005
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR3 GPC3 COL16A1 ITGA8 ABCC9 SNED1 ATRNL1	8.82e-05	197	236	7	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR3 GPC3 COL16A1 ITGA8 ABCC9 SNED1 ATRNL1	8.82e-05	197	236	7	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR3 GPC3 COL16A1 ITGA8 ABCC9 SNED1 ATRNL1	8.82e-05	197	236	7	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HOXB3 GPC3 NHS COL16A1 ITGA8 CCDC80 SNED1	9.10e-05	198	236	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	severe_COVID-19-NK\|severe_COVID-19 / disease group, cell group and cell class (v2)	ZNF276 MLLT6 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 BHLHE40	9.10e-05	198	236	7	7f51e37516f717e424190e6584f1c74d357e2da4
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	MYH9 EMILIN2 SAMD9L PARP14 BHLHE40 OASL KDM2A	9.10e-05	198	236	7	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L ACSS2 ATP13A4 ABCC9 GPAM PPP4R4 NIM1K	9.10e-05	198	236	7	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-CD8+_T_naive\|Int-URO / Disease, condition lineage and cell class	TTC16 IFT172 HOOK1 ZNF257 DZIP3 COPS4 ZNF431	9.10e-05	198	236	7	8c7d00d8c27fb47954d8ac53eebc4582e92b970c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AP1M1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 ARVCF FTH1	9.10e-05	198	236	7	1a189b2b213099505c5d871fb8aedd55a97d44e0
ToppCell	control-Lymphocytic-NK_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MLLT6 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 RHOBTB3 MACF1	9.10e-05	198	236	7	1c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCell	distal-2-Hematologic-Interstitial_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BCKDK EMILIN2 GPR84 CD300C AP2S1 MRC1 FTH1	9.39e-05	199	236	7	d4caf296b6ce22a10b78d0efd4e018d867ccb78a
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ATP6V1B2 EMILIN2 SAP30 CD300C AP2S1 MRC1 FTH1	9.39e-05	199	236	7	7dde5c02fcae64cd2d68f607500f2a46b97851fd
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	JAK2 GPC3 SCARA3 COL16A1 ITGA8 CCDC80 SYTL4	9.39e-05	199	236	7	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ATP6V1B2 ERCC6 VPS16 EHBP1L1 APAF1 KDM2A MARK2	9.39e-05	199	236	7	bbb4798d6a24e756fea744a151ba67c1bafbac9a
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	ATP6V1B1 OSBPL1A GOLGA4 KLHL5 PPP2R5E AKAP9 GCC2	9.39e-05	199	236	7	53ca3861f9e00dab3f3fbefb0837857ee39ab084
Drug	D-Au	SLC29A3 CD300C KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 KIR3DL3	1.30e-06	77	235	8	CID000277822
Drug	Air Pollutants	KDM3A SLC29A3 SAMD9 LHX8 ACSS2 ZNF626 FARP2 PHKB HOOK1 CEP126 ANXA9 LETMD1 RHOBTB3 APAF1 SHMT1 GRB14 CCDC80 GPAM PARP14 RALGAPA2 EPG5 AKAP9 DZIP3 MRAP2 OR51B4 LARGE1	3.30e-06	917	235	26	ctd:D000393
Drug	Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	RRAGB PGAP6 JAK2 ZNF276 HOOK1 TAF1 BAHCC1 SZT2 OASL SENP6 CFAP69	7.15e-06	198	235	11	6315_UP
Disease	level of killer cell immunoglobulin-like receptor 2DS2 in blood serum	KIR2DL1 KIR2DL3 KIR3DL3	4.26e-07	3	223	3	OBA_2042107
Disease	Malignant neoplasm of breast	KDM3A MYH9 ERCC6 BCORL1 PHKB HOOK1 OTOGL NHS AP1M1 UTP20 HERC2 TREML1 NLRP8 RAD51B SHMT1 RUFY1 ZNF546 EPG5 GTF2A1 AKAP9 MACF1 ENPEP	2.42e-05	1074	223	22	C0006142
Disease	Familial monosomy 7 syndrome	SAMD9 SAMD9L	5.69e-05	2	223	2	cv:C5681220
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	ATP13A4 ATP13A5 EPG5 ZNF106	7.46e-05	30	223	4	DOID:332 (implicated_via_orthology)
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	KIR2DL1 KIR2DL3 KIR3DL3	1.81e-04	15	223	3	EFO_0801746
Disease	neuroimaging measurement	SECISBP2L SAMD9 MARK3 HLA-DQB2 SMARCAD1 BAHCC1 INO80E RAD51B EXOC6 MRC1 SZT2 RUFY1 KCTD17 CDC37 ZNF106 CNKSR3 FTH1 COPS4 MACF1 KIF18B	1.94e-04	1069	223	20	EFO_0004346
Disease	juvenile-onset Parkinson's disease (implicated_via_orthology)	ATP13A4 ATP13A5	3.38e-04	4	223	2	DOID:0060893 (implicated_via_orthology)
Disease	Kufor-Rakeb syndrome (implicated_via_orthology)	ATP13A4 ATP13A5	3.38e-04	4	223	2	DOID:0060556 (implicated_via_orthology)
Disease	visual impairment and progressive phthisis bulbi (implicated_via_orthology)	MARK3 MARK2	3.38e-04	4	223	2	DOID:0070356 (implicated_via_orthology)
Disease	diet measurement, body mass index	DOCK1 ATP13A4 ATP13A5	4.42e-04	20	223	3	EFO_0004340, EFO_0008111
Disease	Familial aplasia of the vermis	TCTN1 KIF7 TTC21B	4.42e-04	20	223	3	cv:C0431399
Disease	serum iron measurement	HLA-DQB2 ATP13A4 DUOX2 ATP13A5 KCTD17	4.99e-04	86	223	5	EFO_0006332
Disease	follicular lymphoma (implicated_via_orthology)	ATP6V1B1 ATP6V1B2	5.60e-04	5	223	2	DOID:0050873 (implicated_via_orthology)
Disease	Intellectual Disability	BCKDK KDM3B PTCHD1 SNX27 TAF1 TCTN1 PTPN23 KIF7 ZNF335 MACF1 LARGE1	6.41e-04	447	223	11	C3714756
Disease	orofacial cleft (is_implicated_in)	MYH9 ACSS2	1.16e-03	7	223	2	DOID:0050567 (is_implicated_in)
Disease	ovarian carcinoma (is_marker_for)	BMP7 LETMD1 SMAD2	1.21e-03	28	223	3	DOID:4001 (is_marker_for)
Disease	renal tubular acidosis (implicated_via_orthology)	ATP6V1B1 ATP6V1B2	1.55e-03	8	223	2	DOID:14219 (implicated_via_orthology)
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	HLA-DQB2 GPAM ZNF106 MACF1	1.68e-03	67	223	4	EFO_0008595, EFO_0020946
Disease	cystic kidney disease (implicated_via_orthology)	IFT172 TTC21B	2.46e-03	10	223	2	DOID:2975 (implicated_via_orthology)
Disease	non-alcoholic fatty liver disease	IFT172 HOOK1 MRC1 ITGA8 GPAM ALPK2	2.69e-03	182	223	6	EFO_0003095
Disease	Jeune thoracic dystrophy	IFT172 TTC21B	2.99e-03	11	223	2	C0265275
Disease	colon cancer (biomarker_via_orthology)	JAK2 APAF1 SMAD2	3.18e-03	39	223	3	DOID:219 (biomarker_via_orthology)
Disease	Global developmental delay	KDM3B SNX27 TAF1 SZT2 ZNF335	3.46e-03	133	223	5	C0557874
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A KDM3B ACSS2 GPR21 GRK4 SHMT1	3.77e-03	195	223	6	DOID:1574 (implicated_via_orthology)
Disease	Short Rib-Polydactyly Syndrome	IFT172 TTC21B	4.20e-03	13	223	2	C0036996
Disease	Prader-Willi Syndrome	HERC2 MRAP2	4.20e-03	13	223	2	C0032897
Disease	alkaline phosphatase measurement	SAMD9 CYP2C18 ACACB FARP2 PHKB RIC1 PROCR PBX4 GPAM BHLHE40 TMEM106B GCC2 OASL PRKAR1A MACF1 ALPK2	4.68e-03	1015	223	16	EFO_0004533
Disease	adipose tissue measurement	DOCK1 MMS22L ARHGEF10	4.78e-03	45	223	3	EFO_0004764
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	ATP13A4 ATP13A5	4.87e-03	14	223	2	DOID:14503 (implicated_via_orthology)
Disease	Saldino-Noonan Syndrome	IFT172 TTC21B	4.87e-03	14	223	2	C0036069
Disease	Majewski Syndrome	IFT172 TTC21B	4.87e-03	14	223	2	C0024507
Disease	eye color	BMP7 HOOK1 HERC2 ENPEP	4.89e-03	90	223	4	EFO_0003949
Disease	response to hydrochlorothiazide, fasting blood glucose measurement	ZNF626 OTOGL ZNF106	5.09e-03	46	223	3	EFO_0004465, EFO_0005202
Disease	amyotrophic lateral sclerosis, age at onset	ARAP2 KDM4A	5.60e-03	15	223	2	EFO_0004847, MONDO_0004976
Disease	Autosomal recessive primary microcephaly	KNL1 ZNF335	5.60e-03	15	223	2	cv:C3711387
Disease	dual specificity mitogen-activated protein kinase kinase 2 measurement	LAMP1 PPP4R4	6.36e-03	16	223	2	EFO_0008112
Disease	Abnormal behavior	BCORL1 KDM3B	6.36e-03	16	223	2	C0233514
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	PALD1 EMILIN2 CYTL1 KCNB2 MMS22L RUFY1 NIM1K MACF1	6.74e-03	364	223	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ACACB HLA-DQB2 ANXA9 GRB14 GPAM ZNF106 MACF1	6.88e-03	291	223	7	EFO_0008317, EFO_0020946
Disease	osteoarthritis	RABGAP1 ZNF276 BHLHE40 ATRNL1 SENP6 ALPK2	7.02e-03	222	223	6	MONDO_0005178
Disease	high altitude adaptation	KNTC1 HLA-DQB2	7.18e-03	17	223	2	EFO_0009105
Disease	protein C measurement	MYO7B PROCR	7.18e-03	17	223	2	EFO_0004633

Protein segments in the cluster

Peptide	Gene	Start	Entry
ICAEIAKHSVAQRDY	TTC21B	886	Q7Z4L5
FYREALVHCETDNKI	TTC21B	906	Q7Z4L5
IFLGVEYIFHQCKEN	YBEY	91	P58557
IRKQCNHIFLRFIYE	PPP2R5B	231	Q15173
HAQLAYCIVQFLEKD	PPP2R5E	281	Q16537
YLHDLQVDFLTEKNC	APAF1	436	O14727
FLEDTCVQYVQKHIS	PROCR	181	Q9UNN8
QGICADQVKVFSYHR	EPG5	336	Q9HCE0
IVLQYVPHDRFNKTC	MLLT6	106	P55198
QTISHKCQVVAREQY	BAHCC1	2586	Q9P281
YEAEIHCLQKRLQAV	AKAP9	1361	Q99996
TVFYRVKEILQCHSL	ARHGEF10	466	O15013
LELEKEFHCNRYITI	CDX4	186	O14627
EFHCNRYITIQRKSE	CDX4	191	O14627
DYRKHVLFCGTEVIQ	ATP13A5	341	Q4VNC0
YLQHLCFENEGVKRR	ARVCF	381	O00192
FHKIISRYLLCQADV	ADORA2B	301	P29275
LFLNSSHIYEKQDRC	ALPK2	216	Q86TB3
LKFCQQHDIVITAYS	AKR1D1	206	P51857
DYKRHVLFCGTEVIQ	ATP13A4	341	Q4VNC1
KPVSFDLQQVHIYCD	COL16A1	216	Q07092
FQTCAREVLQYLAKH	BHLHE40	146	O14503
VSQQILEKRAYICAH	ACAD9	601	Q9H845
VVLYCLQKDSEDVNH	BCORL1	1511	Q5H9F3
VKFHQCVRLSRFEND	AP1M1	236	Q9BXS5
EIKIHDLCVRYENNL	ABCC9	1311	O60706
VICLAIHKEDFYLNT	ARAP2	951	Q8WZ64
AAIIEHLYRVQKCSE	ARAP2	1241	Q8WZ64
TNICYNVLDRNVHEK	ACSS2	101	Q9NR19
YCQLVRQLLDDHKDV	BCKDK	151	O14874
QRQACKKHELYVSFR	BMP7	326	P18075
ELRVDHYKCNIQASV	DBF4	476	Q9UBU7
CRLTDEQHKVYQNFV	ERCC6	766	Q03468
NHRKVKTYLNQVCED	ARMCX4	2116	Q5H9R4
YCELAERHIQQIVLF	CCDC80	176	Q76M96
FCLQVKRNDYVHALV	PRMT1	271	Q99873
HNVCELDLVFNFYKV	AP2S1	96	P53680
RNHKEDEAKYISQCI	AP3D1	26	O14617
VQCRYEKEHRTLNKF	CD300C	41	Q08708
HVVQLLYRASCFKVT	RC3H2	241	Q9HBD1
KVHLYRELTCDEVLQ	RAD51B	176	O15315
VLRYCENKFNDKHIT	RAB21	36	Q9UL25
LFLQTVVHCARKTEY	RIC1	896	Q4ADV7
VERENVIEYKHCLIT	JAK2	441	O60674
TYRDCLQALKDEFHQ	LARGE2	681	Q8N3Y3
LQEKLHLRFCYEAVV	PTPN23	1436	Q9H3S7
VTYAQLDHCVFIQRK	KIR3DL2	396	P43630
ITYNCKEEFQIHDEL	PALD1	61	Q9ULE6
ALIEYSCERQHQIIF	MAMDC2	626	Q7Z304
QAHYDKCVINLREQF	ACACB	1146	O00763
CIAASEFYKTRHNII	CACNG2	121	Q9Y698
QNFEDLHCKFYQLER	RABGAP1	686	Q9Y3P9
TYTQLNHCVFTQRKI	KIR2DL2	301	P43627
LYHNLSADECKVRAQ	KAT7	211	O95251
SEQCYRDVSDLKVIH	LARGE1	366	O95461
YKEVQTVSEHIQNCL	MDN1	2771	Q9NU22
CRKKQQENIYSHLDE	IL17RD	321	Q8NFM7
LQRRHSDVKVYKEFC	LIMS3	41	P0CW19
LQRRHSDVKVYKEFC	LIMS4	41	P0CW20
EHLRQFRQDVTKCLF	LETMD1	126	Q6P1Q0
IRHFENKFAVETLIC	ITM2B	251	Q9Y287
VTYAQLNHCVFTQRK	KIR2DL3	301	P43628
LRIYVCHNEYEVKVN	LGALS16	91	A8MUM7
RCQYLHEVELTVTLN	NLRP8	651	Q86W28
YKFIHLNVQEFCTAI	NLRP11	446	P59045
FQEAFEIVVRHAKNY	GPC3	111	P51654
CQYQERLIKLEHAEA	GOLGA4	1771	Q13439
QDHNVKDFLCQIERY	HERC2	1401	O95714
IRQQCVLFLHYVKVF	MMS22L	126	Q6ZRQ5
CRFYQHKFPEVEDVV	EIF2S1	6	P05198
CQVVRELVKYTNHFR	FANCM	226	Q8IYD8
YICERHFQKVLNRSL	DUOX2	1466	Q9NRD8
YEQFIEKCTSHDIQK	FSIP2	5356	Q5CZC0
QERAAVDKVCRHNYE	HLA-DQB2	101	P05538
VTYAQLDHCVFTQRK	KIR3DL1	396	P43629
VIKLACADITFNHIY	OR51B4	181	Q9Y5P0
FFNHEKLISYDQCIV	OR4Q2	86	P0C623
YRHIYLSCKEETNVQ	EFR3B	526	Q9Y2G0
EQLQIHYKVCYARVL	COPS4	181	Q9BT78
LCEEQLTKQVHYDFG	DNAH8	2006	Q96JB1
YAQLNHCVFTQRKIT	KIR3DL3	381	Q8N743
RVCQEKQVDYEINAH	METTL2B	61	Q6P1Q9
AKFQFVACYHELVLE	EHBP1L1	16	Q8N3D4
CKYFDKVVTLREEQH	KIF7	1101	Q2M1P5
LCSKTVEYHRLDQNV	KCT2	236	Q8NC54
VHNLYSCIKVAEDFV	KDM3B	1691	Q7LBC6
ISKHKNGRFYQCEVV	KDM4A	906	O75164
ANITIIEHQKCENAY	KLK11	196	Q9UBX7
VVKQIYQDLFQDCHF	KNL1	2326	Q8NG31
NLHKIQDDEFVVNYC	KNTC1	461	P50748
EFALVEEKVLCRVHY	LHX8	176	Q68G74
CLNEASVLHNLKERY	MYH9	91	P35579
CIEAYQRLDRHAQEK	NALF2	246	O75949
CLAVYKHNFQVEAVD	ANXA9	151	O76027
LVCFAVHQFDSVKRI	ENPEP	286	Q07075
HYQICKNDREELYAV	PGAP6	756	Q9HCN3
HNYCVLDKLRDFVAS	CYTL1	66	Q9NRR1
QIIHRDLKAENVFYT	NIM1K	191	Q8IY84
CYFGHRQVVQDLLKA	OSBPL1A	56	Q9BXW6
RQCRETHKIAVFYIA	RALGAPA2	1641	Q2PPJ7
FVELQVCDHYQRILQ	GARIN1B	151	Q96KD3
ENYLRHKQLCDVILV	KLHL5	211	Q96PQ7
EARQQEKHFEVLISY	KIF18B	141	Q86Y91
KHVYRVLQCQEEELT	KCTD17	141	Q8N5Z5
HYQCEDFKRQLRTVT	DZIP3	761	Q86Y13
HLEQACKYLEDFITN	EXOC6	556	Q8TAG9
IFYCLIHRQVKRAAQ	GPR84	196	Q9NQS5
KSHQCQDFIVYLRDE	ITGA8	576	P53708
LCVEQHVKENTAYFQ	MACF1	776	Q9UPN3
QGFIRKQCVDHYNEV	NDUFA10	176	O95299
DAAINHYIEARCSIK	IFT172	871	Q9UG01
IYEHECFQEELRKAQ	INO80E	26	Q8NBZ0
RVCQEKQVDYEINAH	METTL2A	61	Q96IZ6
YTLHNAIIEDCVRKQ	OASL	281	Q15646
FNQTCSHFRIEKIER	PARP14	1636	Q460N5
QIYHSELEKYEQACR	PBX4	136	Q9BYU1
CDFIETHYLNEQVKA	FTH1	131	P02794
ASKYHDLECQLIQEF	EXOC5	186	O00471
VYCITNRSHLTKEFQ	KDM2A	341	Q9Y2K7
HNCRQDIYHAVSEVK	KCNB2	861	Q92953
VHNLYSCIKVAEDFV	KDM3A	1251	Q9Y4C1
YDELFQIHLKLQCET	CCDC138	181	Q96M89
QLKYHLERQEDLEAC	DOCK1	866	Q14185
QHQVLERKYCVELLN	DOCK2	876	Q92608
ICNQYSHIADKVSEV	DNAH3	701	Q8TD57
SQKYLSDNVHLVCEE	CDC37	171	Q16543
LSERLHYIQESICKN	CEP126	1076	Q9P2H0
VLCQTIIAHKLFDYV	CACNA1I	1161	Q9P0X4
QLATEYNRKQVLRHC	CCDC191	391	Q8NCU4
YVIDLQEEVRKFCVH	CCDC191	821	Q8NCU4
CYTVEQHNREVQSLK	GCC2	416	Q8IWJ2
VELEKEFHFNRYLCR	HOXB3	201	P14651
NCLRKFYKHQNTEVV	CTR9	706	Q6PD62
SVKNYTKCHVRNEQI	ATRNL1	701	Q5VV63
YFSKLRDIELICQEH	MAPRE3	226	Q9UPY8
SAVQYCHQKFIVHRD	MARK2	161	Q7KZI7
RSKFRQIVSAVQYCH	MARK3	156	P27448
RECELYVQKHNIQAL	PRKAR1A	16	P10644
RDVCQLLILKNHYID	GRB14	131	Q14449
YKCNAEEHVRVTKAF	LAMP1	336	P11279
VKNKYECEIQASRQH	BRMS1L	131	Q5PSV4
NVICSVIFHDRFDYK	CYP2C18	176	P33260
KFVVSHLICQYAQVV	AHCTF1	656	Q8WYP5
RINVTEKNAEEHCFY	EMILIN2	456	Q9BXX0
YRVHCEELEKQLIEF	HOOK1	271	Q9UJC3
KAFEECTRVAHNYLR	GRK4	141	P32298
KICVEYHTFFRLLDQ	FARP2	311	O94887
YFNIFRICQQHTKDI	GPR21	211	Q99679
RIQICKCIVDFYHAE	CFAP69	156	A5D8W1
QECYDVKAAVHQINF	SCARA3	211	Q6AZY7
TYTQLNHCVFTQRKI	KIR2DL1	301	P43626
AVQQLLEKNYRIHCS	DIMT1	246	Q9UNQ2
LEKNYRIHCSVHNII	DIMT1	251	Q9UNQ2
IQNIIYYKCNTHDER	PHKB	831	Q93100
TIYNINIESHLRFCK	OTOGL	2301	Q3ZCN5
YQVSRLQHICELFII	RHOBTB3	501	O94955
DTRQFLIYNEDHKRC	MRC1	21	P22897
LIYNEDHKRCVDAVS	MRC1	26	P22897
TLEFKVYQHQVVANC	SHMT1	321	P34896
YEQQTQSLVVHVKEC	SYTL4	366	Q96C24
QAAAEEKHTCVVQYI	SZT2	856	Q5T011
YDFCTLISIKVHNIV	TMEM106B	211	Q9NUM4
CNYQPRVHLKTVVFQ	SLC29A3	396	Q9BZD2
TAEFLAYQCEKHVLV	ATP6V1B2	281	P21281
AEFLAYQCEKHVLVI	ATP6V1B1	276	P15313
YHEQLALKTDCQERL	UTP20	801	O75691
YITDVVKLNAFDQRH	UTP20	1426	O75691
KTVDDVLIHCQVIYD	SCML1	56	Q9UN30
QYETCLKDINRAQTH	SMYD4	121	Q8IYR2
CIFLRYNRKQEQRHE	PPP4R4	551	Q6NUP7
TDFELHVLCKQYRHI	SMARCAD1	826	Q9H4L7
ICDYHKNLIQSVRNR	SAP30	111	O75446
VFVTEQYNDHLDKVR	NHS	681	Q6T4R5
EIHKANVVCVVYDVS	RHOT2	71	Q8IXI1
KAFQVLYREHCEAIV	RFX1	606	P22670
IENNYQHSIFCRKVP	PTCHD1	431	Q96NR3
ERSYHLDKCQIALNI	SAMD9L	1001	Q8IVG5
YFEDHQVQQAKKCIR	SAMD9	271	Q5K651
AEHQERYKEECQRIF	TAF1	1056	P21675
DQKNYVEELNRHLSC	RUFY1	306	Q96T51
QRDCYLKVSQSKEHQ	GPAM	701	Q9HCL2
ITKIHSKRFREYCNQ	SECISBP2L	666	Q93073
VANHVKYFKVRVCQE	IMPG2	101	Q9BZV3
VLYQVFHDTICEKEA	SPEM1	56	Q8N4L4
VLQEAHKQYRCVDSY	SPAG17	796	Q6Q759
KRVYRVHQDICFKES	SNED1	1376	Q8TER0
QIDHIKQCRAEYDTK	CLHC1	136	Q8NHS4
DCLQQYVHKFEREKI	CNK3/IPCEF1	21	G9CGD6
DCLQQYVHKFEREKI	CNKSR3	21	Q6P9H4
KQECEQIAFRLFTHR	NEU3	391	Q9UQ49
QEHVVKEELLNALYC	SUPT6H	946	Q7KZ85
TENVVVCQYDKIHRS	GTF2A1	331	P52655
FQQVILRRYGKCEHE	ZNF431	126	Q8TF32
CQLLEHKEHRYQFIE	TRIM24	246	O15164
VCQYLREEEQKHVES	TRIM77	186	I1YAP6
FETQRQLHEERPYKC	ZNF394	346	Q53GI3
KAFICCTYLQIHERI	ZNF441	426	Q8N8Z8
ECGNAFYVKVRLIEH	ZNF157	446	P51786
IEVFVEVAHKQICYL	XPO4	856	Q9C0E2
RYKCEQVFNEKVHVT	ZNF549	221	Q6P9A3
QVHKRGVVEYEAQCS	POLR3C	66	Q9BUI4
FHCYINEVERLDRAK	MRAP2	116	Q96G30
YRTVHQYNKEQLCLE	RLF	1331	Q13129
KEYLCVQQAELDHLS	RIPOR3	86	Q96MK2
RDLYATVTHNVCEQK	SAGE1	196	Q9NXZ1
FDTDNVIVCQYDKIH	GTF2A1L	431	Q9UNN4
HELKAIENCEYAFNL	SMAD2	141	Q15796
FLVISHYQCKEQRDV	RRAGA	211	Q7L523
LSLYRQFCKHQELET	VPS16	601	Q9H269
HFSLCVNVVLEVKYS	TCTN1	316	Q2MV58
ECRKAFRQQSYLIQH	ZNF546	221	Q86UE3
VKLIHTEVRNYICDE	ZNF276	486	Q8N554
FQAVRNIYGCKHVEK	ZNF534	136	Q76KX8
NRQVIHIADKTYKCS	ZNF534	216	Q76KX8
QLCSKRYREFAILHQ	SNX27	191	Q96L92
DIIVNCDDSKHTYLQ	SENP6	286	Q9GZR1
TFLVISHYQCKEQRD	RRAGB	271	Q5VZM2
VQICELEKRFHRQKY	TLX3	176	O43711
QEVILRQYKKCRHEN	ZNF730	96	Q6ZMV8
HNFEYSICQETLLEK	ZNF33A	216	Q06730
FREVQKNTHGLEYQC	ZNF347	131	Q96SE7
QKVVLRRYEKCEHDN	ZNF626	96	Q68DY1
TVNVNKEQVYSLEHC	TOPAZ1	1656	Q8N9V7
YKCSEREQRFIQHLD	ZSCAN26	231	Q16670
IREKAYKCNEHGQVF	ZNF528	181	Q3MIS6
CEITFRYKQQLATHL	ZNF212	321	Q9UDV6
QHKRIQTRVNFYKCE	ZNF117	126	Q03924
EHVRIHTQEQLYKCE	ZNF57	381	Q68EA5
HVDNGIRYKFDVTQC	TRMT12	201	Q53H54
YKQAVHELVRCVALT	TTC23	61	Q5W5X9
IEKALEYFTCALQHR	TTC37	696	Q6PGP7
QDNCKHLERLTFVLY	TTC16	126	Q8NEE8
RHYAKLNFVIDDSCI	ZMYM1	1031	Q5SVZ6
RNVLCVIETFHKYAS	TCHHL1	6	Q5QJ38
RKSQLIYHENICIQE	ZNF614	216	Q8N883
VQCHYRLQDVKAQKV	TREML1	36	Q86YW5
THIQAVANRRFKCEF	ZNF335	611	Q9H4Z2
SAILQKCHFYEVLSE	VIRMA	551	Q69YN4
SCHAQAVLKIINYRD	USP7	131	Q93009
ACLDKFVRVYELQSH	ZNF106	1756	Q9H2Y7
AERENFHRLCENYIK	UNC45A	386	Q9H3U1
HQRVHTEEKFYKIEC	ZNF214	321	Q9UL59
EVNYQNVVHKLCSDA	ZMYM4	456	Q5VZL5
DNIDRSVIYSQKICH	PP2D1	151	A8MPX8
QKVILRRYDKCEHEN	ZNF257	96	Q9Y2Q1
QVCKAHNDLLRTYEA	GAS8	426	O95995
AAEQNVSRICHKIYF	MYO7B	1791	Q6PIF6